Further evidence for the association of genetic variants of ZNF804A with schizophrenia and a meta-analysis for genome-wide significance variant rs1344706

Schizophrenia Research

Volumn 141, Issue 1, 2012, Pages 40-47

  Zhang, Rui ^a   Yan, Ji Dong ^a   Valenzuela, Robert K ^b   Lu, She Min ^a   Du, Xiao Yun ^a   Zhong, Bo ^a   Ren, Juan ^a   Zhao, Si Hai ^a   Gao, Cheng Ge ^a   Wang, Lei ^c   Guo, Ting Wei ^d   Ma, Jie ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b MARSHFIELD CLINIC   (United States)

^c FUDAN UNIVERSITY   (China)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Meta analysis; Non synonymous variants; Schizophrenia; SNPs; ZNF804A

Indexed keywords

PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN 804A;

ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANTEL HAENSZEL TEST; MARKER GENE; META ANALYSIS (TOPIC); PATHOGENESIS; PRIORITY JOURNAL; SAMPLE SIZE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; ZNF804A GENE;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84865998735     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.07.013     Document Type: Article

References (43)

1. Akey J., Jin L., Xiong M. Haplotypes vs single marker linkage disequilibrium tests: what do we gain?. Eur. J. Hum. Genet. 2001, 9(4):291-300.
2. Balog Z., Kiss I., Keri S. ZNF804A may be associated with executive control of attention. Genes Brain Behav. 2011, 10(2):223-227.
3. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
4. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
5. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136(2):215-233.
6. Beveridge N.J., Cairns M.J. MicroRNA dysregulation in schizophrenia. Neurobiol. Dis. 2012, 46(2):263-271.
7. Chung H.J., Lee J.Y., Deocaris C.C., Min H., Kim S.H., Kim M.H. Mouse homologue of the schizophrenia susceptibility gene ZNF804A as a target of Hoxc8. J. Biomed. Biotechnol. 2010, 2010:231708.
8. Clayton D., Jones H. Transmission/disequilibrium tests for extended marker haplotypes. Am. J. Hum. Genet. 1999, 65(4):1161-1169.
9. Donohoe G., Morris D.W., Corvin A. The psychosis susceptibility gene ZNF804A: associations, functions, and phenotypes. Schizophr. Bull. 2010, 36(5):904-909.
10. Donohoe G., Rose E., Frodl T., Morris D., Spoletini I., Adriano F., Bernardini S., Caltagirone C., Bossu P., Gill M., Corvin A.P., Spalletta G. ZNF804A risk allele is associated with relatively intact gray matter volume in patients with schizophrenia. Neuroimage 2011, 54(3):2132-2137.
11. Dwyer S., Williams H., Holmans P., Moskvina V., Craddock N., Owen M.J., O'Donovan M.C. No evidence that rare coding variants in ZNF804A confer risk of schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B(8):1411-1416.
12. Esslinger C., Walter H., Kirsch P., Erk S., Schnell K., Arnold C., Haddad L., Mier D., Opitz von Boberfeld C., Raab K., Witt S.H., Rietschel M., Cichon S., Meyer-Lindenberg A. Neural mechanisms of a genome-wide supported psychosis variant. Science 2009, 324(5927):605.
13. Esslinger C., Kirsch P., Haddad L., Mier D., Sauer C., Erk S., Schnell K., Arnold C., Witt S.H., Rietschel M., Cichon S., Walter H., Meyer-Lindenberg A. Cognitive state and connectivity effects of the genome-wide significant psychosis variant in ZNF804A. Neuroimage 2011, 54(3):2514-2523.
14. Hansen T., Olsen L., Lindow M., Jakobsen K.D., Ullum H., Jonsson E., Andreassen O.A., Djurovic S., Melle I., Agartz I., Hall H., Timm S., Wang A.G., Werge T. Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One 2007, 2(9):e873.
15. Hashimoto R., Ohi K., Yasuda Y., Fukumoto M., Iwase M., Iike N., Azechi M., Ikezawa K., Takaya M., Takahashi H., Yamamori H., Okochi T., Tanimukai H., Tagami S., Morihara T., Okochi M., Tanaka T., Kudo T., Kazui H., Iwata N., Takeda M. The impact of a genome-wide supported psychosis variant in the ZNF804A gene on memory function in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B(8):1459-1464.
16. Hill M.J., Jeffries A.R., Dobson R.J., Price J., Bray N.J. Knockdown of the psychosis susceptibility gene ZNF804A alters expression of genes involved in cell adhesion. Hum. Mol. Genet. 2012, 21(5):1018-1024.
17. Lencz T., Szeszko P.R., DeRosse P., Burdick K.E., Bromet E.J., Bilder R.M., Malhotra A.K. A schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypes. Neuropsychopharmacology 2010, 35(11):2284-2291.
18. Li M., Luo X.J., Xiao X., Shi L., Liu X.Y., Yin L.D., Diao H.B., Su B. Allelic differences between Han Chinese and Europeans for functional variants in ZNF804A and their association with schizophrenia. Am. J. Psychiatry 2011, 168(12):1318-1325.
19. Lin M., Pedrosa E., Shah A., Hrabovsky A., Maqbool S., Zheng D., Lachman H.M. RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders. PLoS One 2011, 6(9):e23356.
20. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., Dwyer S., Holmans P., Marchini J.L., Spencer C.C., Howie B., Leung H.T., Hartmann A.M., Moller H.J., Morris D.W., Shi Y., Feng G., Hoffmann P., Propping P., Vasilescu C., Maier W., Rietschel M., Zammit S., Schumacher J., Quinn E.M., Schulze T.G., Williams N.M., Giegling I., Iwata N., Ikeda M., Darvasi A., Shifman S., He L., Duan J., Sanders A.R., Levinson D.F., Gejman P.V., Cichon S., Nothen M.M., Gill M., Corvin A., Rujescu D., Kirov G., Owen M.J., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Cloninger C.R. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 2008, 40(9):1053-1055.
21. O'Donovan M.C., Craddock N.J., Owen M.J. Genetics of psychosis; insights from views across the genome. Hum. Genet. 2009, 126(1):3-12.
22. Owen M.J., Craddock N., O'Donovan M.C. Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia. Arch. Gen. Psychiatry 2010, 67(7):667-673.
23. Pedrosa E., Sandler V., Shah A., Carroll R., Chang C., Rockowitz S., Guo X., Zheng D., Lachman H.M. Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells. J. Neurogenet. 2011, 25(3):88-103.
24. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460(7256):748-752.
25. Rasetti R., Sambataro F., Chen Q., Callicott J.H., Mattay V.S., Weinberger D.R. Altered cortical network dynamics: a potential intermediate phenotype for schizophrenia and association with ZNF804A. Arch. Gen. Psychiatry 2011, 68(12):1207-1217.
26. Riley B., Thiselton D., Maher B.S., Bigdeli T., Wormley B., McMichael G.O., Fanous A.H., Vladimirov V., O'Neill F.A., Walsh D., Kendler K.S. Replication of association between schizophrenia and ZNF804A in the Irish case-control study of schizophrenia sample. Mol. Psychiatry 2010, 15(1):29-37.
27. Ripke S., Sanders A.R., Kendler K.S., Levinson D.F., Sklar P., Holmans P.A., Lin D.Y., Duan J., Ophoff R.A., Andreassen O.A., Scolnick E., Cichon S., St Clair D., Corvin A., Gurling H., Werge T., Rujescu D., Blackwood D.H., Pato C.N., Malhotra A.K., Purcell S., Dudbridge F., Neale B.M., Rossin L., Visscher P.M., Posthuma D., Ruderfer D.M., Fanous A., Stefansson H., Steinberg S., Mowry B.J., Golimbet V., De Hert M., Jonsson E.G., Bitter I., Pietilainen O.P., Collier D.A., Tosato S., Agartz I., Albus M., Alexander M., Amdur R.L., Amin F., Bass N., Bergen S.E., Black D.W., Borglum A.D., Brown M.A., Bruggeman R., Buccola N.G., Byerley W.F., Cahn W., Cantor R.M., Carr V.J., Catts S.V., Choudhury K., Cloninger C.R., Cormican P., Craddock N., Danoy P.A., Datta S., de Haan L., Demontis D., Dikeos D., Djurovic S., Donnelly P., Donohoe G., Duong L., Dwyer S., Fink-Jensen A., Freedman R., Freimer N.B., Friedl M., Georgieva L., Giegling I., Gill M., Glenthoj B., Godard S., Hamshere M., Hansen M., Hansen T., Hartmann A.M., Henskens F.A., Hougaard D.M., Hultman C.M., Ingason A., Jablensky A.V., Jakobsen K.D., Jay M., Jurgens G., Kahn R.S., Keller M.C., Kenis G., Kenny E., Kim Y., Kirov G.K., Konnerth H., Konte B., Krabbendam L., Krasucki R., Lasseter V.K., Laurent C., Lawrence J., Lencz T., Lerer F.B., Liang K.Y., Lichtenstein P., Lieberman J.A., Linszen D.H., Lonnqvist J., Loughland C.M., Maclean A.W., Maher B.S., Maier W., Mallet J., Malloy P., Mattheisen M., Mattingsdal M., McGhee K.A., McGrath J.J., McIntosh A., McLean D.E., McQuillin A., Melle I., Michie P.T., Milanova V., Morris D.W., Mors O., Mortensen P.B., Moskvina V., Muglia P., Myin-Germeys I., Nertney D.A., Nestadt G., Nielsen J., Nikolov I., Nordentoft M., Norton N., Nothen M.M., O'Dushlaine C.T., Olincy A., Olsen L., O'Neill F.A., Orntoft T.F., Owen M.J., Pantelis C., Papadimitriou G., Pato M.T., Peltonen L., Petursson H., Pickard B., Pimm J., Pulver A.E., Puri V., Quested D., Quinn E.M., Rasmussen H.B., Rethelyi J.M., Ribble R., Rietschel M., Riley B.P., Ruggeri M., Schall U., Schulze T.G., Schwab S.G., Scott R.J., Shi J., Sigurdsson E., Silverman J.M., Spencer C.C., Stefansson K., Strange A., Strengman E., Stroup T.S., Suvisaari J., Terenius L., Thirumalai S., Thygesen J.H., Timm S., Toncheva D., van den Oord E., van Os J., van Winkel R., Veldink J., Walsh D., Wang A.G., Wiersma D., Wildenauer D.B., Williams H.J., Williams N.M., Wormley B., Zammit S., Sullivan P.F., O'Donovan M.C., Daly M.J., Gejman P.V. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 43(10):969-976.
28. Schanze D., Ekici A.B., Gawlik M., Pfuhlmann B., Reis A., Stober G. Evaluation of risk loci for schizophrenia derived from genome-wide association studies in a German population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2011, 156(2):198-203.
29. Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe'er I., Dudbridge F., Holmans P.A., Whittemore A.S., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Crowe R.R., Oksenberg J.R., Mirel D.B., Kendler K.S., Freedman R., Gejman P.V. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460(7256):753-757.
30. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., Boutin P., Vincent D., Belisle A., Hadjadj S., Balkau B., Heude B., Charpentier G., Hudson T.J., Montpetit A., Pshezhetsky A.V., Prentki M., Posner B.I., Balding D.J., Meyre D., Polychronakos C., Froguel P. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445(7130):881-885.
31. Steinberg S., Mors O., Borglum A.D., Gustafsson O., Werge T., Mortensen P.B., Andreassen O.A., Sigurdsson E., Thorgeirsson T.E., Bottcher Y., Olason P., Ophoff R.A., Cichon S., Gudjonsdottir I.H., Pietilainen O.P., Nyegaard M., Tuulio-Henriksson A., Ingason A., Hansen T., Athanasiu L., Suvisaari J., Lonnqvist J., Paunio T., Hartmann A., Jurgens G., Nordentoft M., Hougaard D., Norgaard-Pedersen B., Breuer R., Moller H.J., Giegling I., Glenthoj B., Rasmussen H.B., Mattheisen M., Bitter I., Rethelyi J.M., Sigmundsson T., Fossdal R., Thorsteinsdottir U., Ruggeri M., Tosato S., Strengman E., Kiemeney L.A., Melle I., Djurovic S., Abramova L., Kaleda V., Walshe M., Bramon E., Vassos E., Li T., Fraser G., Walker N., Toulopoulou T., Yoon J., Freimer N.B., Cantor R.M., Murray R., Kong A., Golimbet V., Jonsson E.G., Terenius L., Agartz I., Petursson H., Nothen M.M., Rietschel M., Peltonen L., Rujescu D., Collier D.A., Stefansson H., St Clair D., Stefansson K. Expanding the range of ZNF804A variants conferring risk of psychosis. Mol. Psychiatry 2011, 16(1):59-66.
32. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 2001, 68(4):978-989.
33. Walters J.T., Corvin A., Owen M.J., Williams H., Dragovic M., Quinn E.M., Judge R., Smith D.J., Norton N., Giegling I., Hartmann A.M., Moller H.J., Muglia P., Moskvina V., Dwyer S., O'Donoghue T., Morar B., Cooper M., Chandler D., Jablensky A., Gill M., Kaladjieva L., Morris D.W., O'Donovan M.C., Rujescu D., Donohoe G. Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch. Gen. Psychiatry 2010, 67(7):692-700.
34. Wang W.Y., Barratt B.J., Clayton D.G., Todd J.A. Genome-wide association studies: theoretical and practical concerns. Nat. Rev. Genet. 2005, 6(2):109-118.
35. Wei Q., Kang Z., Diao F., Shan B., Li L., Zheng L., Guo X., Liu C., Zhang J., Zhao J. Association of the ZNF804A gene polymorphism rs1344706 with white matter density changes in Chinese schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 36(1):122-127.
36. Williams H.J., Norton N., Dwyer S., Moskvina V., Nikolov I., Carroll L., Georgieva L., Williams N.M., Morris D.W., Quinn E.M., Giegling I., Ikeda M., Wood J., Lencz T., Hultman C., Lichtenstein P., Thiselton D., Maher B.S., Malhotra A.K., Riley B., Kendler K.S., Gill M., Sullivan P., Sklar P., Purcell S., Nimgaonkar V.L., Kirov G., Holmans P., Corvin A., Rujescu D., Craddock N., Owen M.J., O'Donovan M.C. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol. Psychiatry 2011, 16(4):429-441.
37. Xiao B., Li W., Zhang H., Lv L., Song X., Yang Y., Yang G., Jiang C., Zhao J., Lu T., Zhang D., Yue W. Association of ZNF804A polymorphisms with schizophrenia and antipsychotic drug efficacy in a Chinese Han population. Psychiatry Res. 2011, 190(2-3):379-381.
38. Xu M., St Clair D., He L. Testing for genetic association between the ZDHHC8 gene locus and susceptibility to schizophrenia: an integrated analysis of multiple datasets. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B(7):1266-1275.
39. Zhang X.J., Huang W., Yang S., Sun L.D., Zhang F.Y., Zhu Q.X., Zhang F.R., Zhang C., Du W.H., Pu X.M., Li H., Xiao F.L., Wang Z.X., Cui Y., Hao F., Zheng J., Yang X.Q., Cheng H., He C.D., Liu X.M., Xu L.M., Zheng H.F., Zhang S.M., Zhang J.Z., Wang H.Y., Cheng Y.L., Ji B.H., Fang Q.Y., Li Y.Z., Zhou F.S., Han J.W., Quan C., Chen B., Liu J.L., Lin D., Fan L., Zhang A.P., Liu S.X., Yang C.J., Wang P.G., Zhou W.M., Lin G.S., Wu W.D., Fan X., Gao M., Yang B.Q., Lu W.S., Zhang Z., Zhu K.J., Shen S.K., Li M., Zhang X.Y., Cao T.T., Ren W., Zhang X., He J., Tang X.F., Lu S., Yang J.Q., Zhang L., Wang D.N., Yuan F., Yin X.Y., Huang H.J., Wang H.F., Lin X.Y., Liu J.J. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat. Genet. 2009, 41(2):205-210.
40. Zhang F., Chen Q., Ye T., Lipska B.K., Straub R.E., Vakkalanka R., Rujescu D., St Clair D., Hyde T.M., Bigelow L., Kleinman J.E., Weinberger D.R. Evidence of sex-modulated association of ZNF804A with schizophrenia. Biol. Psychiatry 2011, 69(10):914-917.
41. Zhang R., Lu S.M., Qiu C., Liu X.G., Gao C.G., Guo T.W., Valenzuela R.K., Deng H.W., Ma J. Population-based and family-based association studies of ZNF804A locus and schizophrenia. Mol. Psychiatry 2011, 16(4):360-361.
42. Zhang R., Valenzuela R.K., Lu S., Meng L., Guo T., Du X., Kang W., Ma J. Is the conserved mammalian region of ZNF804A locus associated with schizophrenia? A population-based genetics analysis. Schizophr. Res. 2011, 133(1-3):159-164.
43. Zheng W., Long J., Gao Y.T., Li C., Zheng Y., Xiang Y.B., Wen W., Levy S., Deming S.L., Haines J.L., Gu K., Fair A.M., Cai Q., Lu W., Shu X.O. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat. Genet. 2009, 41(3):324-328.